Skip to content

TO SEE THE EFFECT VIRECHANA KARMA WITH PATOLMULAADI AND MUSTAADI KWATH IN EKKUSHTA (PSORIASIS)

A COMPARITIVE CLINICAL STUDY ON VIRECHANA KARMA WITH PATOLMULAADI AND MUSTAADI KWATH IN EKKUSHTA (PSORIASIS)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/052603
Enrollment
30
Registered
2023-05-12
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B998- Other infectious disease

Interventions

None listed

Sponsors

Patanjali ayurvedic college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients between the age group 18-60 years of either sex. 2.Patients with classical features of Ekkushta explained in classical text. 3.Patients were selected irrespective of sex, occupation, Socio economic status, religion etc 4.Both fresh and treated cases will be selected. 5.Patients fit for Virechana Karma will be taken for the study.

Exclusion criteria

Exclusion criteria: 1.Patients below the age of 18 years and above 60 years were excluded 2.Patients with Hypertension, Cardiac Disorder, Diabetes Mellitus and Major systemic disease. 3.Patients having other Skin Disorders like Chronic Fungal Infection, Tuberculosis, SLE. 4.Psychiatric illness and pregnant women.

Design outcomes

Primary

MeasureTime frame
1.SUBJECTIVE PARAMETER: - Matsyashaklapamam Aswedanam Mahavastum Arun Varna Kandu Rukshata Daha Srava 2. OBJECTIVE PARAMETERS: - Candle Grease Sign Auspitz Sign Koebner phenomenon Timepoint: 21 days

Secondary

MeasureTime frame
1.SUBJECTIVE PARAMETERS:- Matsyashaklapamam Aswedanam Mahavastum Arun Varna Kandu Rukshata Daha Srava 2. OBJECTIVE PARAMETERS: - Candle Grease Sign Auspitz Sign Koebner phenomenon Timepoint: 45 days

Countries

India

Contacts

Public Contactvd Shivani Mahajan

Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan, Haridwar

ramitkumar482@gmail.com8979413938

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026